Risk Factors for Progressive Supranuclear Palsy (PSP)
Trial
N/A
Completed
April 9, 2017
Mild Cognitive Impairment in Parkinson's Disease
Trial
Phase 4
Completed
April 6, 2017
Efficacy and Tolerability of Nebicapone in Parkinson's Disease Patients With "Wearingoff" Phenomenon
Trial
Phase 2
Completed
April 5, 2017
Impact of Rehabilitation in Quality of Life in PD
Trial
N/A
Completed
April 4, 2017
Effectiveness of Intensive Rehabilitation in Advanced Stages of Parkinson's Disease.
Trial
N/A
Unknown
April 3, 2017
Handwriting Rehabilitation in Parkinson Disease
Trial
N/A
Unknown
April 3, 2017
Magnetic Resonance Imaging in the Diagnosis of Parkinsonian Syndromes
Trial
N/A
Terminated
March 30, 2017
Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease
Trial
Phase 4
Completed
March 29, 2017
Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics
Trial
Phase 1
Completed
March 29, 2017
Pharmacokinetic Profile of BIA 6-512 in Healthy Elderly Subjects Versus Healthy Young Subjects
Trial
Phase 1
Completed
March 29, 2017
Blood Lactate Concentrations With and Without Exercise in Parkinson's Disease and Multiple Sclerosis Patients
Trial
N/A
Completed
March 29, 2017
Effect of Food on BIA 6-512 (Trans-resveratrol)
Trial
Phase 1
Completed
March 28, 2017
Tolerability and Steady-state Pharmacokinetics of BIA 6-512
Trial
Phase 1
Completed
March 27, 2017
Pharmacokinetics of Rising Single-doses of BIA 6-512 and Their Effect on the Levodopa Pharmacokinetics
Trial
Phase 1
Completed
March 26, 2017
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Parkinson's Disease
Trial
Phase 1
Completed
March 26, 2017
Tolerability, Safety and Pharmacokinetics of Four Single-doses of BIA 6-512 (Trans-resveratrol) and Their Effect on the Levodopa Pharmacokinetics
Trial
Phase 1
Completed
March 26, 2017
Respiratory Kinematics of Cough in Healthy Older Adults and Parkinson's Disease
Trial
Phase 1
Completed
March 23, 2017